PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-46

  1. 995 Posts.
    lightbulb Created with Sketch. 327
    Happy to be corrected, but 6 month data just needs to show positive direction and 12 month data is the key one? The results show pretty positive results and the hope would be it improves even further?

    I'm not a pharma expert, so please feel free to correct.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.